首页>
外国专利>
Serum biomarker proteins predictive of the resistance to chemotherapy in breast cancer
Serum biomarker proteins predictive of the resistance to chemotherapy in breast cancer
展开▼
机译:血清生物标志物蛋白可预测乳腺癌对化疗的耐药性
展开▼
页面导航
摘要
著录项
相似文献
摘要
PURPOSE: A biomarker for diagnosing resistance to a chemotherapeutic agent in a patient with breast cancer is provided to enable an individual patient to select a treatment direction and to enhance survival rate of the patient without recurrence. CONSTITUTION: A composition for diagnosing resistance to a chemotherapeutic agent in a patient with breast cancer contains antibodies which specifically bind to proteins selected among a group consisting of alpha-2-HS-glycoprotein, apolipoprotein B, complement component 3, complement component 9, ceruloplasmin, and orosomucoid 1. A kit for diagnosing resistance to a chemotherapeutic agent contains the antibodies. A microarray for diagnosing resistance to a chemotherapeutic agent contains the antibodies.
展开▼